A drug screening toolkit based on the -1 ribosomal frameshifting of SARS-CoV-2

Yanqiong Chen1,2,3, Huan Tao4, Silan Shen5,3

  • 1Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, China.

Heliyon
|September 2, 2020
PubMed